Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

globenewswire.com
JNJ Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. MRK Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. ABBV Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. ABT Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. NVS Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. GSK Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. AMGN Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. TEVA Mentioned as a key player in the cancer supportive care products market, indicating its involvement in a growing industry. JAGX The company is highlighted for its innovation with Gelclair, a product launched in the U.S. for managing oral mucositis, suggesting positive developments and market entry. LLY Mentioned for its acquisition of POINT Biopharma Global Inc. to bolster radiopharmaceutical capabilities, indicating strategic growth in the cancer therapy sector.

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030 Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Supportive Care Products Market Report 2026" has been added to ResearchAndMarkets.com's offering. This report offers valuable insights into global market size, regional shares, competitive analysis, and emerging trends, delivering an in-depth perspective critical for thriving in the cancer supportive care products industry.

The global cancer supportive care products market is steadily evolving, with an anticipated growth from $22.47 billion in 2025 to $23.54 billion in 2026 at a CAGR of 4.8%. Historical growth is driven by increasing global cancer prevalence, rising chemotherapy and radiation therapy applications, and a higher incidence of treatment-related side effects. The expansion of hospital-based oncology services and improved access to essential supportive drugs also contribute to this upsurge.

Forecasts indicate a continuous upward trajectory, with market size expected to reach $28.24 billion by 2030 at a CAGR of 4.7%. Several factors fuel this growth, including an aging population with elevated cancer risk, patient-centric oncology care emphasis, heightened awareness of supportive care benefits, and expanding global cancer treatment volumes. Demand for comprehensive symptom management therapies and a quality-of-life-oriented approach foster this trend.

The rising cancer incidence remains a crucial market driver. As populations age, cancer risk escalates due to cellular alterations and extended exposure to risk factors, including lifestyle choices such as smoking, poor diet, inactivity, and excessive alcohol use. Cancer supportive care products address these issues by managing symptoms, enhancing life quality, and supporting patients during treatment.

Companies like Jaguar Health are concentrating on innovations such as Gelclair, a mechanical-action oral mucosal protective gel, to reduce therapy-induced oral mucositis. This product forms a physical barrier over oral mucosa, alleviating pain without numbing effects, thus supporting eating and drinking during treatment. In October 2024, Jaguar Health launched Gelclair in the U.S., promising rapid and sustained pain relief.

Additionally, October 2023 saw Eli Lilly and Company acquiring POINT Biopharma Global Inc. This strategic move aims to bolster Eli Lilly's capabilities in targeted radiopharmaceuticals for cancer therapy, showcasing the industry's dynamic evolution.

Key players in the market include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., and several others, pioneering diverse segments of cancer supportive care. North America led the market in 2025, while Asia-Pacific is projected to be the fastest-growing region moving forward.

Reasons to Purchase:

Market Segments Include:

Highlighted Companies: Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Teva Pharmaceutical Industries Limited, and others.

Geographies and Regions Covered: Includes Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain, and regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Key Attributes

The companies featured in this Cancer Supportive Care Products market report include:

For more information about this report visit https://www.researchandmarkets.com/r/mk1l6v

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment